Fike, Candice D. http://orcid.org/0000-0002-1240-3312
Aschner, Judy L.
Avachat, Charul http://orcid.org/0000-0002-5052-7981
Birnbaum, Angela K. http://orcid.org/0000-0002-3969-4906
Sherwin, Catherine M. T.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R34HL142995)
Article History
Received: 31 May 2023
Revised: 10 October 2023
Accepted: 18 October 2023
First Online: 31 October 2023
Competing interests
: CDF and JLA are inventors on a patent at Vanderbilt University Medical Center that has been licensed to Asklepion Pharmaceuticals for the “Therapeutic treatment of bronchopulmonary dysplasia.”
: All procedures performed in this study involving human participants were in accordance with the 1964 Helsinki Declaration and its later amendments. The study design was approved by the institutional review boards of The University of Utah and Intermountain Healthcare. All participants or legal guardians of participants in the clinical trial included in these analyses provided written informed consent.